Showing results (1131-1140 of 1,380) with videos related to

Sort By:
Pageof 138
Pediatric Blood & Cancer|March 4, 2015
Re-induction chemoimmunotherapy with epratuzumab in relapsed acute lymphoblastic leukemia (ALL): Phase II results from Children's Oncology Group (COG) study ADVL04P2Elizabeth A Raetz, Mitchell S Cairo, Michael J Borowitz, et al.
The Journal of Allergy and Clinical Immunology|June 21, 2023
Diagnosis of vocal cord dysfunction/inducible laryngeal obstruction: An International Delphi Consensus StudyPaul Leong, Anne E Vertigan, Mark Hew, et al.
The Journal of Biological Chemistry|June 5, 2014
Loss of TBL1XR1 disrupts glucocorticoid receptor recruitment to chromatin and results in glucocorticoid resistance in a B-lymphoblastic leukemia modelCourtney L Jones, Teena Bhatla, Roy Blum, et al.
Metabolic Engineering|June 27, 2024
Evolution and engineering of pathways for aromatic O-demethylation in Pseudomonas putida KT2440Alissa C Bleem, Eugene Kuatsjah, Josefin Johnsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2017
Neurocognitive Functioning of Children Treated for High-Risk B-Acute Lymphoblastic Leukemia Randomly Assigned to Different Methotrexate and Corticosteroid Treatment Strategies: A Report From the Children's Oncology GroupKristina K Hardy, Leanne Embry, John A Kairalla, et al.
Bioorganic & Medicinal Chemistry|May 16, 2006
Synthesis of Sansalvamide A derivatives and their cytotoxicity in the MSS colon cancer cell line HT-29Thomas J Styers, Ahmet Kekec, Rodrigo Rodriguez, et al.
Neurology|July 11, 2018
Cutaneous neurofibromas: Current clinical and pathologic issuesNicolas Ortonne, Pierre Wolkenstein, Jaishri O Blakeley, et al.
Pediatric Blood & Cancer|March 2, 2011
Augmented therapy improves outcome for pediatric high risk acute lymphocytic leukemia: results of Children's Oncology Group trial P9906W Paul Bowman, Eric L Larsen, Meenakshi Devidas, et al.
Molecular Ecology Resources|April 4, 2025
Leveraging Synteny to Generate Reference Genomes for Conservation: Assembling the Genomes of Hector's and Māui DolphinsS Alvarez-Costes, C S Baker, R Constantine, et al.
Pediatric Blood & Cancer|June 1, 2023
Minimal residual disease predicts outcomes in KMT2A-rearranged but not KMT2A-germline infant acute lymphoblastic leukemia: Report from Children's Oncology Group study AALL0631Kelly E Faulk, John A Kairalla, ZoAnn E Dreyer, et al.
Pageof 138